Saline versus Balanced Crystalloids for Adults with Aneurysmal Subarachnoid Hemorrhage: A Subgroup Analysis of the SMART Trial.

Akshitkumar M MistryJordan A MagarikMichael J FeldmanLi WangChristopher J LindsellMatthew R FuscoRohan V ChitaleGordon R BernardWesley H SelfTodd W RiceChristopher G HughesEva A MistryMatthew W Semler

Published in: Stroke (Hoboken, N.J.) (2022)

Among procedurally treated aSAH patients, the risk of disability or death at 90 days did not significantly differ between saline and balanced crystalloids. Death occurred less frequently with saline than balanced crystalloids.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
clinical trial
phase iii
multiple sclerosis
study protocol
peritoneal dialysis
randomized controlled trial
phase ii